According to a new study from the Stanford University School of Medicine, the incidence of heart disease and associated fatalities are higher for people who live in poor neighborhoods verses those who live in more affluent areas.
Johns Hopkins cardiologists are calling for an expansion of the criteria widely used by physicians to detect and assess a postmenopausal woman’s chances of developing cardiovascular disease, the leading cause of death among women in the United States.
Federal legislation aimed at fighting the No. 1 killer of American women — heart disease, stroke and other cardiovascular diseases — today received the endorsement of several leading women’s heart and health care organizations.
Researchers have developed a more accurate way to predict the risk of developing cardiovascular disease among women, according to a study in the February 14 issue of JAMA.
The reduction of body iron stores through phlebotomy (blood removal) in patients with peripheral artery disease (PAD) does not appear to decrease the risk of death plus nonfatal cardiovascular events, according to a study published in the February 14 issue of JAMA.
Researchers have developed a more accurate way to predict the risk of developing cardiovascular disease among women, according to a study in the February 14 issue of JAMA.
People who have multiple sclerosis (MS) for 10 years and have few of the disabling symptoms of the disease are often told they have “benign MS” and that their symptoms will likely not ever occur to the same extent as other people with MS.
In a new large, prospective study, researchers found that midday napping — siestas — reduced coronary mortality by about one-third among men and women.
Exposure to second-hand smoke at work, home or elsewhere results in a disproportionate rise in markers that increase the risk of cardiovascular disease, University of Nottingham researchers have found.
Physicians have an effective new option for treating atrial fibrillation, a common irregular heart rhythm that can cause stroke. Heart surgeons at Washington University School of Medicine in St. Louis have developed and tested a device that radically shortens and simplifies a complex surgical procedure that has had the best long-term cure rate for persistent atrial fibrillation.